BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38091580)

  • 1. Temporal trends and transmission dynamics of pre-treatment HIV-1 drug resistance within and between risk groups in Kenya, 1986-2020.
    Nduva GM; Otieno F; Kimani J; Sein Y; Arimide DA; Mckinnon LR; Cholette F; Lawrence MK; Majiwa M; Masika M; Mutua G; Anzala O; Graham SM; Gelmon L; Price MA; Smith AD; Bailey RC; Medstrand P; Sanders EJ; Esbjörnsson J; Hassan AS
    J Antimicrob Chemother; 2024 Feb; 79(2):287-296. PubMed ID: 38091580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 viraemia and drug resistance amongst female sex workers in Soweto, South Africa: A cross sectional study.
    Coetzee J; Hunt G; Jaffer M; Otwombe K; Scott L; Bongwe A; Ledwaba J; Molema S; Jewkes R; Gray GE
    PLoS One; 2017; 12(12):e0188606. PubMed ID: 29244809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High viral suppression and detection of dolutegravir-resistance associated mutations in treatment-experienced Tanzanian adults living with HIV-1 in Dar es Salaam.
    Bwire GM; Aiko BG; Mosha IH; Kilapilo MS; Mangara A; Kazonda P; Swai JP; Swalehe O; Jordan MR; Vercauteren J; Sando D; Temba D; Shao A; Mauka W; Decouttere C; Vandaele N; Sangeda RZ; Killewo J; Vandamme AM
    Sci Rep; 2023 Nov; 13(1):20493. PubMed ID: 37993493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and characteristics of HIV drug resistance among antiretroviral treatment (ART) experienced adolescents and young adults living with HIV in Ndola, Zambia.
    Miti S; Handema R; Mulenga L; Mwansa JK; Abrams E; Frimpong C; Burke VM; Zulu M; Siwingwa M; Mwakazanga D; Kalibala S; Denison JA
    PLoS One; 2020; 15(8):e0236156. PubMed ID: 32804970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High Level of HIV Drug Resistance and Virologic Nonsuppression Among Female Sex Workers in Ethiopia: A Nationwide Cross-Sectional Study.
    Arimide DA; Amogne MD; Kebede Y; Balcha TT; Adugna F; Ramos A; DeVos J; Zeh C; Agardh A; Chih-Wei Chang J; Björkman P; Medstrand P
    J Acquir Immune Defic Syndr; 2022 Apr; 89(5):566-574. PubMed ID: 34966147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 Subtype Diversity and Factors Affecting Drug Resistance among Patients with Virologic Failure in Antiretroviral Therapy in Hainan Province, China, 2014-2020.
    Yu E; Xu YJ; Li M; Yang Y; Liang HY; Zhong SM; Qin C; Lan YN; Li DW; Yu JP; Pang Y; Qin XQ; Liang H; Zhu KK; Ye L; Liang BY
    Biomed Environ Sci; 2023 Sep; 36(9):800-813. PubMed ID: 37803893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to antiretroviral drugs in newly diagnosed, young treatment-naïve HIV-positive pregnant women in the province of KwaZulu-Natal, South Africa.
    Parboosing R; Naidoo A; Gordon M; Taylor M; Vella V
    J Med Virol; 2011 Sep; 83(9):1508-13. PubMed ID: 21739439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 Drug Resistance, Distribution of Subtypes, and Drug Resistance-Associated Mutations in Virologic Failure Individuals in Chengdu, Southwest China, 2014-2016.
    Chen J; Liu Y; Liu S; Yuan D; Su L; Ye L; Gong F; Gao Y; Baloch S; Pei X
    Biomed Res Int; 2020; 2020():5894124. PubMed ID: 32280691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increasing proportions of HIV-1 non-B subtypes and of NNRTI resistance between 2013 and 2016 in Germany: Results from the national molecular surveillance of new HIV-diagnoses.
    Hauser A; Hofmann A; Meixenberger K; Altmann B; Hanke K; Bremer V; Bartmeyer B; Bannert N
    PLoS One; 2018; 13(11):e0206234. PubMed ID: 30408827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 subtype diversity, transmission networks and transmitted drug resistance amongst acute and early infected MSM populations from Coastal Kenya.
    Hassan AS; Esbjörnsson J; Wahome E; Thiong'o A; Makau GN; Price MA; Sanders EJ
    PLoS One; 2018; 13(12):e0206177. PubMed ID: 30562356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of acquired and transmitted HIV drug resistance in Iran: a systematic review and meta-analysis.
    Mirzaei H; Eybpoosh S; Mehrabi F; Shojaei MR; Mirzazadeh A; Khezri M; Nasiri N; Sharifi H
    BMC Infect Dis; 2024 Jan; 24(1):29. PubMed ID: 38166733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age and CD4+ T cell counts are inversely associated with HIV drug resistance mutations in treatment naive female sex workers.
    Mulinge MM; Oluoch JO; Abisi HK; Otieno LE; Anzala O; Wamalwa DC; Nduati RW; Kimani J; Herbeck J; McKinnon L
    Medicine (Baltimore); 2023 Jun; 102(24):e34060. PubMed ID: 37327289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The HIV care continuum and HIV-1 drug resistance among female sex workers: a key population in Guinea-Bissau.
    Lindman J; Djalo MA; Biai A; Månsson F; Esbjörnsson J; Jansson M; Medstrand P; Norrgren H;
    AIDS Res Ther; 2020 Jun; 17(1):33. PubMed ID: 32532294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparisons of Primary HIV-1 Drug Resistance between Recent and Chronic HIV-1 Infection within a Sub-Regional Cohort of Asian Patients.
    Kiertiburanakul S; Chaiwarith R; Sirivichayakul S; Ditangco R; Jiamsakul A; Li PC; Kantipong P; Lee C; Ratanasuwan W; Kamarulzaman A; Sohn AH; Sungkanuparph S;
    PLoS One; 2013; 8(6):e62057. PubMed ID: 23826076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of transmitted HIV drug resistance among recently-infected antenatal clinic attendees in four Central African countries.
    Aghokeng AF; Vergne L; Mpoudi-Ngole E; Mbangue M; Deoudje N; Mokondji E; Nambei WS; Peyou-Ndi MM; Moka JJ; Delaporte E; Peeters M
    Antivir Ther; 2009; 14(3):401-11. PubMed ID: 19474474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of HIV-1 molecular epidemiology and transmitted drug-resistance in newly diagnosed HIV-infected patients in Sichuan, China.
    Zhou C; Liang S; Li Y; Zhang Y; Li L; Ye L; Yuan D; Su L
    BMC Infect Dis; 2022 Jul; 22(1):602. PubMed ID: 35799101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquired HIV drug resistance among adults living with HIV receiving first-line antiretroviral therapy in Rwanda: A cross-sectional nationally representative survey.
    Musengimana G; Tuyishime E; Kiromera A; Malamba SS; Mulindabigwi A; Habimana MR; Baribwira C; Ribakare M; Habimana SD; DeVos J; Mwesigwa RCN; Kayirangwa E; Semuhore JM; Rwibasira GN; Suthar AB; Remera E
    Antivir Ther; 2022 Jun; 27(3):13596535221102690. PubMed ID: 35593031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 drug resistance in antiretroviral-naive individuals with HIV-1-associated tuberculous meningitis initiating antiretroviral therapy in Vietnam.
    Thao VP; Le T; Török EM; Yen NT; Chau TT; Jurriaans S; van Doorn HR; de Jong MD; Farrar JJ; Dunstan SJ
    Antivir Ther; 2012; 17(5):905-13. PubMed ID: 22473024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sociodemographic, Ecological, and Spatiotemporal Factors Associated with Human Immunodeficiency Virus Drug Resistance in Florida: A Retrospective Analysis.
    Rich SN; Poschman K; Hu H; Mavian C; Cook RL; Salemi M; Spencer EC; Prosperi M
    J Infect Dis; 2021 Mar; 223(5):866-875. PubMed ID: 32644119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Drug Resistance Levels Compromise the Control of HIV Infection in Pediatric and Adult Populations in Bata, Equatorial Guinea.
    Rodríguez-Galet A; Ventosa-Cubillo J; Bendomo V; Eyene M; Mikue-Owono T; Nzang J; Ncogo P; Gonzalez-Alba JM; Benito A; Holguín Á
    Viruses; 2022 Dec; 15(1):. PubMed ID: 36680067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.